CanniMed Therapeutics (CMED) has notable insider buying

CanniMed Therapeutics (T:CMED)

Douglas Banzet, a Director and 10% Holder executive, acquired 12,532 Common Shares on a direct ownership basis at prices ranging from $1.680 and $4.682 through an exercise of options on November 29th, 2017. This represents a $37,063 investment into the company's shares and an account share holdings change of greater than 100%.

CanniMed Therapeutics Inc is a Canada-based plant biopharmaceutical company. It is specialized in the production of pharmaceutical-grade cannabis and offers a range of pharmaceutical-grade cannabis products. In addition, the Company has a plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. The Company, through its subsidiary CanniMed Ltd, offers medical cannabis oils, dried medical cannabis, vaporizers, vaporizer parts and accessories. Its CanniMed Oils are made using only dried cannabis flowers. Its vaporizers include Arizer Air vaporizer and Volcano Medic vaporizer. Its vaporizer parts and accessories include ARIZER AIR All Glass Tube (no mouthpiece), ARIZER AIR Charger/Power Adapter, ARIZER AIR Dual Battery Charger, ARIZER AIR Glass Tube with black mouthpiece, ARIZER AIR Replacement Battery, Volcano Medic Air Filter Cap and Volcano Medic Air Filter Set.